Should there be a moratorium on the use of cholesterol lowering drugs?

No abstract is available for this paper.

• Publication year

  1992

• Venue

  British medical journal

• Publication date

  1992-02-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/bmj.304.6824.431PMID 1532138PMCID PMC1881265
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• What if Americans ate less fat?

  1992cited by this paper
• Plasma cholesterol concentration and mortality. The Whitehall Study.

  1992cited by this paper
• Antihypertensive Therapy: To Stop or Not to Stop?

  1991cited by this paper
• Long-term mortality after 5-year multifactorial primary prevention of cardiovascular diseases in middle-aged men.

  1991cited by this paper
• Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle Aged Men with Dyslipidemia

  1991cited by this paper
• What if Americans ate less fat? A quantitative estimate of the effect on mortality.

  1991cited by this paper
• Might treatment of hypercholesterolaemia increase non-cardiac mortality?

  1991cited by this paper
• Cost effectiveness of incremental programmes for lowering serum cholesterol concentration: is individual intervention worth while?

  1991cited by this paper
• The potential and limitations of meta-analysis.

  1991cited by this paper
• Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia.

  1991cited by this paper
• Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease.

  1991cited by this paper
• Low serum cholesterol and the risk of cancer: an analysis of the published prospective studies

  1991cited by this paper
• Prescribed use of cholesterol-lowering drugs in the United States, 1978 through 1988.

  1990cited by this paper
• An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence.

  1990cited by this paper
• Expanded clinical evaluation of lovastatin (EXCEL) study: design and patient characteristics of a double-blind, placebo-controlled study in patients with moderate hypercholesterolemia.

  1990cited by this paper
• Lovastatin and simvastatin prevention studies.

  1990cited by this paper
• Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials.

  1990cited by this paper
• Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial. Findings related to a priori hypotheses of the trial. The Multiple Risk Factor Intervention Trial Research Group.

  1990cited by this paper
• Lowering cholesterol concentrations and mortality

  1990cited by this paper
• Lowering cholesterol concentrations and mortality

  1990cited by this paper
• Serum cholesterol and risk of accidental or violent death in a 25-year follow-up. The Finnish cohorts of the Seven Countries Study.

  1989cited by this paper
• A comparison of statistical methods for combining event rates from clinical trials.

  1989cited by this paper
• Test of Effect of Lipid Lowering by Diet on Cardiovascular Risk: The Minnesota Coronary Survey

  1989cited by this paper
• How-often-that-high graphs of serum cholesterol. Findings from the Scottish Heart Health and Scottish MONICA studies.

  1989cited by this paper
• Overview of results of randomized clinical trials in heart disease. II. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification.

  1988cited by this paper
• Reducing cholesterol does not reduce mortality.

  1988cited by this paper
• Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel.

  1988cited by this paper
• Blood lipid concentrations and other cardiovascular risk factors: distribution, prevalence, and detection in Britain

  1988cited by this paper
• Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

  1987cited by this paper
• Strategies for reducing coronary heart disease and desirable limits for blood lipid concentrations: guidelines of the British Hyperlipidaemia Association.

  1987cited by this paper
• Cholesterol reduction and life expectancy. A model incorporating multiple risk factors.

  1987cited by this paper
• Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society.

  1987cited by this paper
• European collaborative trial of multifactorial prevention of coronary heart disease.

  1987cited by this paper
• Cholesterol reduction and life expectancy.

  1987cited by this paper
• The Oslo Study: diet and antismoking advice. Additional results from a 5-year primary preventive trial in middle-aged men.

  1985cited by this paper
• Lowering Blood Cholesterol to Prevent Heart Disease

  1985cited by this paper
• The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease.

  1984cited by this paper
• Blood lipids in middle-aged British men.

  1983cited by this paper
• A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate.

  1979cited by this paper
• Dietary prevention of coronary heart disease: the Finnish Mental Hospital Study.

  1979cited by this paper
• Colestipol hydrochloride in hypercholesterolemic patients--effect on serum cholesterol and mortality.

  1978cited by this paper
• A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.

  1978cited by this paper
• Effect of cholesterol-lowering diet on mortality from coronary heart-disease and other causes. A twelve-year clinical trial in men and women.

  1972cited by this paper
• A Controlled Clinical Trial of a Diet High in Unsaturated Fat in Preventing Complications of Atherosclerosis

  1969cited by this paper

• Discriminating dyslipidemias - a South African perspective

  2025cites this paper
• Anti-hyperlipidemic and Biochemical Effect of Aqueous Extract of Combretum dolichopetalum in High Cholesterol Diet Fed Rats

  2025cites this paper
• In the wake of the Scandinavian Simvastatin Survival Study trial

  2025cites this paper
• Therapeutic and nutritive uses of Macrotyloma uniflorum (Lam.) Verdc. (Horsegram), a somewhat neglected plant of the family Fabaceae

  2023cites this paper
• Lipid profile of the ethanol-methanol (1:1) extracts of Anacadium occidentale and Jatropha tanjorensis administration in Wistar rats

  2022cites this paper
• Pharmacological evaluation of Typha domingensis for its potentials against diet-induced hyperlipidemia and associated complications

  2022cites this paper
• HYPOLIPIDEMIC AND ANTI-OXIDATIVE ACTIVITIES OF TERMINALIA ARJUNA BARKS AGAINST INDUCED HYPERLIPIDEMIC ALBINO RATS

  2021cites this paper
• A New Era for Preventive Cardiology.

  2021cites this paper
• Phytochemical screening and the effect of Trichosanthes dioica in high‐fat diet induced atherosclerosis in Wistar rats

  2021cites this paper
• Statins: Rationale, Mode of Action, and Side Effects

  2019cites this paper
• Biotechnological production of statins: metabolic aspects and genetic approaches.

  2019cites this paper
• LIPID LOWERING ACTIVITY OF A POLYHERBAL FORMULATION ON TRITON WR-1339 (TYLOXAPOL) INDUCED HYPERLIPIDEMIA IN WISTAR RATS Lipid Lowering Activity of a Polyherbal Formulation on WR-1339 Induced in Rats.

  2018cites this paper
• The need for information on trends in the ordering of cho lesterol tests

  2018cites this paper
• In-vivo biological effect of Carica papaya leave extracts on P-407 induced hyperlipidemic Albino Wistar rats

  2018cites this paper
• The final word about LDL-cholesterol lowering.

  2018cites this paper
• Anti-Hyperlipidemic Effect of Vitex Doniana Ethanol Extract in Poloxamer Induced Hyperlipidemia

  2018cites this paper
• Statins use and cancer: an update.

  2018cites this paper
• In-vivo biological effect of Carica papaya leaf extracts on P-407 induced hyperlipidemic Wistar rats

  2018cites this paper
• Anti-hyperlipidemic effect of Vitex doniana in poloxamer induced hyperlipidemia

  2018cites this paper
• Efficacy and safety of cholesterol-lowering treatment : prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

  2017cites this paper
• Interpretation of the evidence for the efficacy and safety of statin therapy.

  2016cites this paper
• Effect of Terminalia bellerica against high fat diet induced hyperlipidemia and obesity

  2016cites this paper
• Long-Term Effectiveness and Safety of Pravastatin in Patients With Coronary Heart Disease: Sixteen Years of Follow-Up of the LIPID Study

  2016cites this paper
• The idea of uniform change: is it time to revisit a central tenet of Rose's "Strategy of Preventive Medicine"?

  2016cites this paper
• JAMIA Knowledge Representation

  2016cites this paper
• Don’t ignore the Cochrane reviews on statins

  2016cites this paper
• Convergence Study for Relationship Between Cholesterol Level on Serum and Depression in Korean Adults

  2015cites this paper
• Design Strategy for a Smoking Cessation Trial of Survival

  2015cites this paper
• Thyroid Hormones and Prevention of Atherosclerotic Heart Disease: An Old-New Hypothesis

  2015cites this paper
• Active Phytoconstituents for Controlling Hypercholesterolemia: A Review

  2015cites this paper
• ANTI-HYPERLIPIDEMICACTIVITY OF TAMARIX GALLICA EXTRACTS IN TRITON X-100 INDUCED HYPERLIPIDEMIC RATS

  2015cites this paper
• The " Lipid " Hypothesis : Gradual Acceptance of a Causal Role Part 4 . High-Carbohydrate Diets and Triglycerides : A Lipoprotein Pitfall ? Part

  2015cites this paper
• HYPOLIPIDEMIC EFFECT OF BIFLAVONOID FRACTION FROM ROOT BARK, STEM BARK AND SEED OF GARCINIA KOLA ON POLOXAMER 407 INDUCED HYPERLIPIDEMIC RATS

  2014cites this paper
• HYPOLIPIDEMIC ACTIVITY OF ETHANOLIC EXTRACTS OF CASSIA ANGUSTIFOLIA IN TRITON- X 100 INDUCED HYPERLIPIDEMIA IN RATS

  2014cites this paper
• Role of an Ethanolic Extract of Crotalaria juncea L. on High-Fat Diet-Induced Hypercholesterolemia

  2014cites this paper
• Statins use and risk of depression: a systematic review and meta-analysis.

  2014cites this paper
• Antihypercholesterolemic and Antioxidative Potential of an Extract of the Plant, Piper betle, and Its Active Constituent, Eugenol, in Triton WR-1339-Induced Hypercholesterolemia in Experimental Rats

  2014cites this paper
• Will new statin guidelines lead to overtreatment?

  2014cites this paper
• ANTI-HYPERLIPIDEMIC ACTIVITY OF TRICHOPUS ZEYLANICUS LEAVES AGAINST HIGH FAT DIET AND TRITON X- 100 INDUCED HYPERLIPIDEMIA

  2014cites this paper
• Role of Boswellia ovalifoliolata Bal. Henry extract on high fat diet induced hypercholesterolemia

  2014cites this paper
• Eff ects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals: a randomised controlled trial

  2013cites this paper
• Synthesis of new andrographolide derivatives and evaluation of their antidyslipidemic, LDL-oxidation and antioxidant activity.

  2013cites this paper
• Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 , 536 high-risk individuals

  2013cites this paper
• ANTIHYPERLIPIDEMIC ACTIVITY OF SUAEDA MARITIMA (L.) DUMORT IER STEM IN TRITON I N DUCED HYPER LIPIDEMIC RATS

  2013cites this paper
• HYPOLIPIDAEMIC ACTIVITY OF Punica granatum FLOWERS ON HYDROGENATED GROUNDNUT OIL INDUCED HYPERCHOLESTEROLEMIC RATS

  2013cites this paper
• Antihypercholesterolemic Effect of Macrotyloma uniflorum (Lam.) Verdc (Fabaceae) Extract on High-Fat Diet-Induced Hypercholesterolemia in Sprague-Dawley Rats

  2013cites this paper
• Hypolipidemic activity of ethyl acetate fraction of methanolic seed extract of Persia Americana mill (Lauraceae) in rats

  2013cites this paper
• Research Article Anti hyperlipidemic Activity of Costus Igneus in Triton X- 100 Induced Hyperlipidemic Rats

  2012cites this paper
• ANTI-HYPERLIPIDEMIC ACTIVITY OF ALCOHOLIC AND METHONOLIC EXTRACTS OF CROTOLARIA JUNCEA IN TRITON-WR 1339 INDUCED HYPERLIPIDEMIA

  2012cites this paper
• Use of Fibrates and Cancer Risk: A Systematic Review and Meta-Analysis of 17 Long-Term Randomized Placebo-Controlled Trials

  2012cites this paper
• ANTIHYPERLIPIDEMICS: EFFECT OF APPLE CIDER VINEGAR ON LIPID PROFILES

  2012cites this paper
• El tratamiento del colesterol alterado en una encrucijada terapéutica

  2012cites this paper
• Chapter 18 – Physiological and Laboratory Markers of Drug Effect

  2012cites this paper
• Effect of Optional Consumption of Iranian Black and Green Tea on Lipid Profile of Serum and Liver in High-Fat Diet Rats

  2012cites this paper
• Anti hyperlipidemic Activity of Costus Igneus in Triton X- 100 Induced Hyperlipidemic Rats

  2012cites this paper
• Hypolipidemic potential of ethanolic extract of Verbesina encelioides Benth. roots.

  2011cites this paper
• ANTIOXIDANT AND ANTICHOLESTEROL ACTIVITIES OF MORINDA CITRIFOLIA L. LINN IN RATS

  2011cites this paper
• Statins and safety: can we finally be reassured?

  2011cites this paper
• The rise of cholesterol testing: how much is unnecessary.

  2011cites this paper
• Hypolipidemic activity of Pithecellobium Dulce Bench . in Triton Wr-1339 Induced Hyperlipidemic Rats

  2011cites this paper
• Journal for Drugs and Medicines

  2011cites this paper
• Anti-hyperlipidemic and antioxidant potential of different fractions of Terminalia arjuna Roxb. bark against PX- 407 induced hyperlipidemia.

  2011cites this paper
• Antihyperlipidemic activity of Bauhinia purpurea extracts in hypercholesterolemic albino rats

  2011cites this paper
• EVALUATIOOF ATIHYPERLIPIDEMIC AD ATIOXIDAT ACTIVITY OF PTEROSPERMUM ACERIFOLIUM (L.)WILLD.

  2011cites this paper
• EVALUATIO OF A TIHYPERLIPIDEMIC A D A TIOXIDA T ACTIVITY OF PTEROSPERMUM

  2011cites this paper
• Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals: a randomised controlled trial

  2011cites this paper
• Antihyperlipidemic activity of Gymenma sylvestre R. Br. leaf extract on rats fed with high cholesterol diet.

  2010cites this paper
• Structure-binding activity relations of amphiphilic polymers and macrophage scavenger receptors: implications for therapeutic inhibition of atherosclerosis

  2010cites this paper
• Reply to discussion of ‘Empirical vs natural weighting in random effects meta‐analysis’

  2010cites this paper
• Hypolipidemic activity of Sesbania grandiflora in triton wr-1339 induced hyperlipidemic rats

  2010cites this paper
• The cost-effectiveness of different blood-cholesterol-lowering strategies in the prevention of coronary heart disease.

  2010cites this paper
• Effect of Erythrina variegata seed extract on hyperlipidemia elicited by high-fat diet in wistar rats

  2010cites this paper
• Lipid-lowering drugs and risk for cancer

  2009cites this paper
• [Cholesterol--a marker for multiple risk factors? A comparison between coronary disease and coronary health].

  2008cites this paper
• MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20536 high-risk individuals : a randomised placebo-controlled trial.

  2008cites this paper
• Anti Hyperlipidemic Activity of Pedalium murex (Linn.) Fruits on High Fat Diet Fed Rats

  2008cites this paper
• A method for the meta‐analysis of mutually exclusive binary outcomes

  2008cites this paper
• History of the cholesterol controversy in Britain.

  2008cites this paper
• CHAPTER 17 – Physiological and Laboratory Markers of Drug Effect

  2007cites this paper
• As restated by Davey Smith and Pekkanen in their review of primary prevention trials in hypercholesterolaemia,2 there has been an excess of non-cardiac deaths with cholesterol lowering drugs5 and no decrease in mortality with diets

  2007cites this paper
• Low serum LDL cholesterol levels and the risk of fever, sepsis, and malignancy.

  2007cites this paper
• Hypercholesterolemia; Management of Korean Patients in New Millennium

  2007cites this paper
• A systematic review and economic evaluation of statins for the prevention of coronary events.

  2007cites this paper
• Sequence Variation in Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease Gene, Low LDL Cholesterol, and Cancer Incidence

  2007cites this paper
• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

  2007cites this paper
• Statins: are any questions unanswered?

  2006cites this paper
• The role of statins in clinical medicine--LDL--cholesterol lowering and beyond.

  2006cites this paper
• Cholesterol, Atherosclerosis and Coronary Disease in the UK, 1950–2000, vol. 27.

  2006cites this paper
• In the Shadow of the “Statin Festival”

  2006cites this paper
• Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence

  2006cites this paper
• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

  2005cites this paper
• High Blood Cholesterol and Cardiovascular Deaths in Women

  2005cites this paper
• Journal of Negative Results in Biomedicine Open Access the "statinth" Wonder of the World: a Panacea for All Illnesses or a Bubble about to Burst

  2005cites this paper
• The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient.

  2005cites this paper
• Lipids Workshop IV Participants

  2005cites this paper
• Inhibidores de la HMG-CoA reductasa, angiogénesis y cáncer

  2005cites this paper
• The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393]

  2005cites this paper
• Statins and hepatotoxicity: Focus on patients with fatty liver

  2005cites this paper
• Lowering cholesterol for prevention of coronary heart disease—Problems and perspectives

  2004cites this paper
• The association between 3‐hydroxy‐3‐methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women

  2004cites this paper